- Home
- NBTB vs CNTA Comparison
NBTB vs CNTA Comparison
Compare NBTB & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTB
- CNTA
- Stock Information
- Founded
- NBTB 1856
- CNTA 2020
- Country
- NBTB United States
- CNTA United Kingdom
- Employees
- NBTB 2083
- CNTA N/A
- Industry
- NBTB Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- NBTB Finance
- CNTA Health Care
- Exchange
- NBTB Nasdaq
- CNTA Nasdaq
- Market Cap
- NBTB 2.3B
- CNTA 2.3B
- IPO Year
- NBTB N/A
- CNTA 2021
- Fundamental
- Price
- NBTB $42.89
- CNTA $21.93
- Analyst Decision
- NBTB Buy
- CNTA Strong Buy
- Analyst Count
- NBTB 3
- CNTA 11
- Target Price
- NBTB $52.33
- CNTA $30.60
- AVG Volume (30 Days)
- NBTB 159.6K
- CNTA 1.5M
- Earning Date
- NBTB 10-27-2025
- CNTA 11-11-2025
- Dividend Yield
- NBTB 3.42%
- CNTA N/A
- EPS Growth
- NBTB 7.37
- CNTA N/A
- EPS
- NBTB 2.77
- CNTA N/A
- Revenue
- NBTB $591,283,000.00
- CNTA $15,000,000.00
- Revenue This Year
- NBTB $27.02
- CNTA N/A
- Revenue Next Year
- NBTB $11.44
- CNTA N/A
- P/E Ratio
- NBTB $15.60
- CNTA N/A
- Revenue Growth
- NBTB 14.42
- CNTA 118.88
- 52 Week Low
- NBTB $37.31
- CNTA $9.60
- 52 Week High
- NBTB $52.44
- CNTA $23.24
- Technical
- Relative Strength Index (RSI)
- NBTB 46.28
- CNTA 71.52
- Support Level
- NBTB $42.91
- CNTA $21.47
- Resistance Level
- NBTB $43.79
- CNTA $23.24
- Average True Range (ATR)
- NBTB 0.79
- CNTA 1.25
- MACD
- NBTB -0.19
- CNTA 0.57
- Stochastic Oscillator
- NBTB 2.05
- CNTA 84.57
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.